Picard Medical, Inc.
PMI
$0.16
-$0.01-7.17%
AMEX
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 85.48% | 20.69% | 34.73% | 206.05% | -68.69% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 85.48% | 20.69% | 34.73% | 206.05% | -68.69% |
| Cost of Revenue | -10.53% | -14.57% | -15.25% | 109.20% | -16.62% |
| Gross Profit | 176.82% | 202.21% | 80.68% | 66.75% | -144.36% |
| SG&A Expenses | 38.99% | -1.78% | -14.38% | 5.96% | 4.58% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 46.43% | -8.98% | -12.23% | 24.94% | 0.36% |
| Operating Income | -38.97% | 15.93% | 21.53% | 7.92% | -73.40% |
| Income Before Tax | -37.72% | 51.58% | -68.00% | -65.74% | -183.01% |
| Income Tax Expenses | -- | 126.67% | -- | -- | -- |
| Earnings from Continuing Operations | -36.95% | 51.45% | -68.00% | -65.74% | -184.60% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -36.95% | 51.45% | -68.00% | -65.74% | -184.60% |
| EBIT | -38.97% | 15.93% | 21.53% | 7.92% | -73.40% |
| EBITDA | -39.36% | 16.06% | 21.72% | 8.97% | -85.20% |
| EPS Basic | 87.15% | 95.14% | 77.92% | -13.41% | -141.60% |
| Normalized Basic EPS | 91.27% | 93.54% | 75.49% | -49.28% | -182.37% |
| EPS Diluted | 87.15% | 95.14% | 77.92% | -13.41% | -141.60% |
| Normalized Diluted EPS | 91.27% | 93.54% | 75.49% | -49.28% | -182.37% |
| Average Basic Shares Outstanding | 834.77% | 827.77% | 585.48% | 11.02% | 0.25% |
| Average Diluted Shares Outstanding | 834.77% | 827.77% | 585.48% | 11.02% | 0.25% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |